Search

Plasmodium falciparum (P. falciparum) malaria continues to pose a significant threat to public health worldwide, particularly in endemic areas. While the majority of cases can be effectively treated and cured, recurrences of P. falciparum malaria are not uncommon and can occur years following initial exposure. This phenomenon adds a new level of complexity to the management and prevention of the disease. The present study describes the compelling clinical case of a patient who contracted malaria despite not having been in an endemic region for over a decade. The patient had previously been infected and treated for the same disease. With low parasitemia, the patient was successfully treated with anti-malarial drugs; however, certain aspects of his medical history remained unclear. The present study also discusses the possibility that this case represents P. falciparum recrudescence or cryptic malaria, drawing on existing literature to contextualize the findings. The case presented herein highlights the need for continued vigilance in the diagnosis and treatment of P. falciparum malaria, particularly in instances of recurrence. Furthermore, it underscores the ongoing challenges posed by this persistent and insidious disease. [ABSTRACT FROM AUTHOR]

A dramatic increasing immigration flow was recorded in Europe during the last years. Only in Sicily 120,239 people arrived in 2014. Immigrants may carry neglected tropical diseases endemic in their origin countries. The aim of our study was to evaluate the frequency of geo-helminthiasis, and in particular of intestinal taeniasis, in a sample of migrants hosted in a large asylum seeker centre in the province of Catania. A stool sample was obtained from all the enrolled subjects and a coproparasitological examination was performed. Out of the 274 enrolled subjects (249 men; mean age 26.4 ± 6.2), 30 (11%) carried at least one helminthic infestation. Ancylostomatidae, Trichuris trichiura and Taenia species (spp) were the most common, the latter found in 6 (2.16%) subjects. T. solium carriers can represent a focus of infection for the more complex neurocysticercosis. Even if coproparasitological examination did not allow us to differentiate Taenia spp, we cannot exclude the presence of T. solium carriers among these subjects. Further studies, including coproantigen ELISA to detect Taenia spp, should be carried out in larger samples to better estimate the real burden of T. solium carriers. [ABSTRACT FROM AUTHOR]

Blastocystis hominis, previously considered a harmless yeast, is now classified as a protozoan inhabiting the human intestinal tract. The pathogenicity of B. hominis remains controversial and is currently the subject of extensive debate.1- 5 As a result of the uncertainty surrounding the pathogenic role of B. hominis, large-scale treatment trials of B. hominis infection have so far been lacking. In spite of this, several drugs have been reported to be active against the parasite.6-8 The present study was carried out in order to evaluate the efficacy of metronidazole treatment in inducing clinical remission and parasitologic eradication in immunocompetent individuals with B. hominis as the only evident cause of diarrhea. [ABSTRACT FROM AUTHOR]

Deals with a study which evaluated the efficacy of metronidazole treatment in inducing clinical remission and parasitologic eradication in immunocompetent individuals with Blastocystis hominis. Patients and methods; Results; Discussion.